Stratify Genomics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $29M

Stratify Genomics General Information

Description

Manufacture of decision tools and test kits designed to screen prostate cancer. The company's test kits can be performed with a cheek-swab sample, at any age, thereby helping men to know their risk for prostate cancer.

Contact Information

Website
www.promptpgs.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3525 Del Mar Heights Road
  • Suite 891
  • San Diego, CA 92130
  • United States
Primary Industry
Diagnostic Equipment
Acquirer
Invitae
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3525 Del Mar Heights Road
  • Suite 891
  • San Diego, CA 92130
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stratify Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 23-Dec-2021 $29M Completed Generating Revenue
2. Seed Round 24-Jul-2019 Completed Generating Revenue
1. Seed Round 05-Jun-2019 $500K $500K Completed Generating Revenue
To view Stratify Genomics’s complete valuation and funding history, request access »

Stratify Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series 3
Series 2
Series 1 10,681,804 $0.000100 $0.11 $0.11 1x $0.11 13.46%
To view Stratify Genomics’s complete cap table history, request access »

Ready to get started?

Request a free trial

Stratify Genomics FAQs

  • When was Stratify Genomics founded?

    Stratify Genomics was founded in 2018.

  • Where is Stratify Genomics headquartered?

    Stratify Genomics is headquartered in San Diego, CA.

  • What industry is Stratify Genomics in?

    Stratify Genomics’s primary industry is Diagnostic Equipment.

  • Is Stratify Genomics a private or public company?

    Stratify Genomics is a Private company.

  • What is the current valuation of Stratify Genomics?

    The current valuation of Stratify Genomics is .

  • What is Stratify Genomics’s current revenue?

    The current revenue for Stratify Genomics is .

  • How much funding has Stratify Genomics raised over time?

    Stratify Genomics has raised $2.7M.

  • When was Stratify Genomics acquired?

    Stratify Genomics was acquired on 23-Dec-2021.

  • Who acquired Stratify Genomics?

    Stratify Genomics was acquired by Invitae.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process